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Abstract
Introduction It has been suggested that doctors in their
first year of post-graduate training make a disproportionate
number of prescribing errors.
Objective This study aimed to compare the prevalence of
prescribing errors made by first-year post-graduate doctors
with that of errors by senior doctors and non-medical
prescribers and to investigate the predictors of potentially
serious prescribing errors.
Methods Pharmacists in 20 hospitals over 7
prospectively selected days collected data on the
number of medication orders checked, the grade of
prescriber and details of any prescribing errors.
Logistic regression models (adjusted for clustering by
hospital) identified factors predicting the likelihood of
prescribing erroneously and the severity of prescribing
errors.
Results Pharmacists reviewed 26,019 patients and
124,260 medication orders; 11,235 prescribing errors
were detected in 10,986 orders. The mean error rate was
8.8 % (95 % confidence interval [CI] 8.6–9.1) errors per
100 medication orders. Rates of errors for all doctors in
training were significantly higher than rates for medical
consultants. Doctors who were 1 year (odds ratio [OR]
2.13; 95 % CI 1.80–2.52) or 2 years in training (OR
2.23; 95 % CI 1.89–2.65) were more than twice as likely
to prescribe erroneously. Prescribing errors were 70 %
(OR 1.70; 95 % CI 1.61–1.80) more likely to occur at the
time of hospital admission than when medication orders
were issued during the hospital stay. No significant dif-
ferences in severity of error were observed between
grades of prescriber. Potentially serious errors were more
Key Points
Foundation year 1 and year 2 doctors were both more
than twice as likely to prescribe erroneously when
compared against medical consultant error rates.
No significant differences in severity of error were
observed between grades of prescriber.
Interventions are needed for all grades of staff, not
just junior doctors, to reduce potentially serious
prescribing errors.
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likely to be associated with prescriptions for parenteral
administration, especially for cardiovascular or endocrine
disorders.
Conclusion The problem of prescribing errors in
hospitals is substantial and not solely a problem of the
most junior medical prescribers, particularly for those
errors most likely to cause significant patient harm.
Interventions are needed to target these high-risk
errors by all grades of staff and hence improve patient
safety.
1 Introduction
Improving patient safety in healthcare settings is a major
concern globally [1]. Medicines are the most commonly
used clinical intervention in healthcare, and errors involv-
ing the prescribing, dispensing, administration and moni-
toring steps of medication use are common [2–4]. Such
medication errors can prolong hospital stay and lead to
significant patient morbidity and even death [5, 6]. Each
year in England alone, the cost of preventable harm from
medicines has been estimated at £750 million [7].
Prescribing errors in hospitals are particularly common;
our systematic review of 65 studies, which used a variety of
data collection methods, found a median prescribing error
rate of 7 % (interquartile range [IQR] 2–14) per medication
order, 52 errors (IQR 8–227) per 100 hospital admissions
and 24 (IQR 6–216) per 1000 patient days [2]. Error
severity was assessed in 74 % of studies, but comparison
between studies was impossible due to the disparity of
assessment methods used. Most previous studies were also
conducted in only one or two hospitals. Two recent studies
conducted in up to nine hospitals in Britain found that 10.9
and 7.5 % of medication items were prescribed incorrectly
[8, 9]. Errors have been presumed to be made more com-
monly by junior doctors, particularly those in their first
year after graduating from university [10]. The PROTECT
study [9] found that doctors who were in their first and
second years of training made more errors than did con-
sultants (7.4 and 8.6 vs. 6.3 %), but Seden et al. [8] found
no difference between error rates of different grades of
doctor.
Severity of errors has been measured in a variety of
ways in published studies, making direct comparison
between studies impossible in our systematic review [2].
Recent work has suggested there was no association
between grades of doctors and the proportion of errors
categorised as significant or higher [8] when correcting for
types of prescription and ward speciality. However, whe-
ther other factors such as type of drug or route of admin-
istration affect the risk of harm to patients is not known.
This study aimed to identify the prevalence of pre-
scribing errors made by junior doctors compared with those
made by their senior colleagues and other non-medical
prescribers and to investigate predictors of the potentially
serious prescribing errors they made.
2 Methods
This large prospective study was undertaken in 20 UK
National Health Service (NHS) hospitals located across the
north-west of England, with data being collected over 7
selected weekdays, each approximately 1 month apart.
Three of the hospitals used electronic prescribing at some
or all stages of a patient’s admission. We used an estab-
lished definition of a prescribing error as ‘‘one which
occurs when, as a result of a prescribing decision or pre-
scription-writing process, there is an unintended, signifi-
cant reduction in the probability of treatment being timely
and effective, or increase in the risk of harm when com-
pared with generally accepted practice’’ [11]. The defini-
tion has been extensively used in previous studies [2, 8, 9]
and is accompanied by lists of situations that should be
included and excluded as prescribing errors.
Lead pharmacists from each of the hospitals involved in
the study attended two training events, each followed by a
question and answer session conducted by DMA and PJL.
The lead pharmacists subsequently provided training on
data collection at their hospitals to all pharmacists partic-
ipating in the study, supported by an information booklet
providing detailed information on definitions and study
requirements. At the study hospitals, inpatient medication
orders were written by prescribers (or rewritten when
required) directly onto a combined prescription and nursing
administration chart, known as ‘the drug chart’ (normal UK
practice). Hospital pharmacists screened all newly pre-
scribed or rewritten inpatient medication orders for pre-
scribing errors as part of their routine pharmacy practice.
Data collection occurred between 08:30 and 17:00, Mon-
day to Friday, but included a review of prescriptions
written outside these hours. In the UK, ward-based clinical
pharmacists routinely check inpatient prescriptions at, or
soon after, patient admission, when medicines reconcilia-
tion is undertaken. Errors identified at hospital admission
may include incorrectly ascertaining and prescribing
patients’ usual long-term medication. Inpatient drug charts
are routinely checked at least daily during weekdays by
ward-based clinical pharmacists. Discharge prescriptions
are also checked and authorised by a pharmacist prior to
supply of medication. Electronic prescription orders could
be checked either on the hospital wards or in the hospital
pharmacy. Pharmacists may amend or clarify some aspects
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of prescribing or discuss with the clinical team any rec-
ommendations or safety issues at these points of care.
Data were collected on the number of medication orders
checked, the grade and type of prescriber (Table 1), the
stage of admission when prescribed (on admission, newly
prescribed or rewritten during the stay or at discharge) and
the number and nature of any prescribing errors. Medica-
tions involved in errors were categorised according to the
relevant chapter in the British National Formulary (BNF)
[12].
2.1 Error Validation
Two validation panels were formed, both comprising two
hospital clinicians and two pharmacists, and both of them
met on several occasions to assess prescribing errors
reported by pharmacists. The panels verified that each
report represented a genuine prescribing error, categorised
the type of error that it represented and judged its perceived
severity. Panel members discussed each error until con-
sensus was achieved. Severity categories included minor,
significant, serious, or potentially lethal errors and were
based on rating scales used in previous medication error
research [13, 14]. Additional details about the severity
classification scheme are provided in the appendix avail-
able in the Electronic Supplementary Material.
2.2 Data Analysis
The denominator for calculating the prescribing error rate
was the number of newly written regular, ‘when required’
and discharge medication orders screened by hospital
pharmacists, including any medication orders omitted
[15]. All confidence intervals (CIs) were calculated at
95 %.
Univariable and multivariable logistic regression models
were developed to examine the potential impact of the
following variables on the likelihood of a prescribing error:
type of prescriber, type of prescription (handwritten vs.
electronic), and the stage of hospital stay at which the
medication order was issued. Multinomial logistic regres-
sion models identified factors predicting the severity of a
prescribing error, particularly which factors were associ-
ated with a significant or potentially serious error rather
than a minor error. All regression models were also
adjusted for clustering by hospital site.
3 Results
Over the 7 days of data collection, 26,019 patients and
124,260 medication orders were reviewed by pharmacists.
Of these, 10,986 medication orders had prescribing errors,
resulting in 11,235 prescribing errors being detected. The
mean prescribing error rate was 8.8 % (95 % CI 8.6–9.1)
errors per 100 medication orders. Prescribing error rates
presented by type of prescriber and stage of hospital stay
are shown in Table 2.
When expressed by the stage of hospital stay, the error
rate associated with medication orders at the time of hos-
pital admission (13.3 %, 95 % CI 12.8–13.8) was higher
than when newly prescribed medication was initiated dur-
ing the hospital stay (7.5 %, 95 % CI 7.1–7.9) or when
medication was prescribed on discharge from hospital
(6.3 %, 95 % CI 5.9–6.7). Foundation doctors (FY1 and
FY2) wrote the majority of medication orders (68 %) and
Table 1 Details of prescriber
types in the study hospitals
Prescriber types in hospital
practice
Description
Foundation year 1 Doctors who have recently completed their undergraduate medical degree
and who have provisional registration with the UK GMC, in their first
year of post-graduate training
Foundation year 2 Doctors in their second year of post-graduate medical training who are
fully registered with the GMC
Fixed-term specialty training
appointments
Doctors in speciality training programmes (usually for 6 years)
Non-consultant career grade
staff
Doctors who have reached a certain level in training and stay working at
that level without completing their training
Consultants Doctors who hold a certificate for the completion of training (usually after
8 years of training)
Pharmacist prescribers Supplementary or independent prescribing pharmacists registered with the
General Pharmaceutical Council
Nurse prescribers Supplementary or independent prescribing nurses registered with the
Nursing and Midwifery Council
GMC General Medical Council
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had the highest prescribing error rates (FY1 8.6 %, 95 %
CI 8.2–8.9; FY2 10.2 %, 95 % CI 9.7–10.7) in comparison
with other types of prescriber.
3.1 Types of Prescribing Errors, Drug Classes
Involved and Severity of Errors
Omission of required drug therapy at the time of hospital
admission was by far the most common type of error,
occurring almost three times as frequently as the next most
numerous type of error, and accounting for 28.5 % of all
prescribing errors (Table 3). Under-dosage (10.9 %) and
over-dosage (8.4 %) of medication were the next most
common error types. Almost half of the errors related to the
need for drug therapy (43.5 %), 5.2 % related to selection
of a specific drug, 23.5 % related to selection of a dosage
regimen, 12.9 % related to administration of a drug, and
14.9 % related to providing a drug product.
Cardiovascular, central nervous system, respiratory,
endocrine, and gastrointestinal drugs were the five most
common therapeutic categories associated with prescribing
errors, accounting for 73.1 % of all medications involved
in errors. Severity grading found that 41.1 % of prescribing
errors were minor, 51.6 % were significant and the
remaining 7.3 % were serious or potentially life threaten-
ing. The rate of potentially serious prescribing errors was
higher for consultants and nurse prescribers than all other
types of prescriber, as shown in Table 4.
3.2 Predictors of Likelihood of Prescribing Error
After controlling for the type of prescriber, prescribing
stage and type of prescription, significant differences were
observed for all three explanatory variables (Table 5). The
multivariable model indicated there were significantly
higher rates of prescribing errors for all types of prescriber
when compared against consultant prescribing error rates,
with FY1 (odds ratio [OR] 2.13; 95 % CI 1.80–2.52) and
FY2 (OR 2.23; 95 % CI 1.89–2.65) doctors being more
than twice as likely to prescribe erroneously as consultants.
No significant differences were identified for prescribing
error rates for pharmacists (OR 0.84; 95 % CI 0.36–1.93)
or nurse prescribers (OR 1.00; 95 % CI 0.71–1.39) when
compared against consultant prescribing error rates.
Likewise, the stage of hospital stay was also found to be
an important predictor of the likelihood of prescribing
errors after controlling for the type of prescriber and the
type of prescription. Medication orders issued at the time
of hospital admission were 70 % more likely to be asso-
ciated with a prescribing error (OR 1.70; 95 % CI
1.61–1.80) than those issued during the hospital stay. In
contrast, prescribing errors were 52 % less likely (OR 0.48;
95 % CI 0.43–0.52) on drug charts that were rewritten and
23 % less likely on discharge prescriptions (OR 0.77; 95 %
CI 0.72–0.82) than medication orders issued during the
hospital stay. Electronic prescriptions were 12 % less
likely to be associated with a prescribing error than were
Table 3 Frequency of prescribing errors by error type
Error type Errors
N % (95 % CI)
Need for drug therapy
Omission on admission 3197 28.46 (26.96–29.95)
Omission on rewrite of prescription
chart
105 0.93 (0.72–1.15)
Omission on discharge 675 6.01 (5.29–6.72)
Premature discontinuation 21 0.19 (0.1–0.27)
Drug not prescribed but indicated 92 0.82 (0.63–1.01)
Continuation for longer than
needed
84 0.75 (0.57–0.93)
No indication 109 0.97 (0.76–1.18)
Duplication 605 5.38 (4.85–5.92)
Selection of a specific drug
Significant allergy 38 0.34 (0.23–0.45)
Clinical contra-indication 120 1.07 (0.86–1.27)
Continuation after ADR 24 0.21 (0.12–0.31)
Drug interaction 60 0.53 (0.39–0.68)
Unintentional prescription of drug 344 3.06 (2.71–3.42)
Selection of dosage regimen
No maximum dose 396 3.52 (3.1–3.95)
Drug interaction not taken into
account
14 0.12 (0.05–0.2)
Dose/rate mismatch 1 0.01 (0–0.03)
No dosage alteration after levels out
of range
6 0.05 (0.01–0.1)
Daily dose divided incorrectly 49 0.44 (0.3–0.57)
Overdose 948 8.44 (7.88–8.99)
Underdose 1226 10.91 (10.24–11.58)
Administration of drug
Incorrect route 117 1.04 (0.81–1.27)
Incorrect formulation 403 3.59 (3.18–3.99)
Administration times incorrect/
missing
736 6.55 (6.01–7.09)
IV instructions incorrect/missing 106 0.94 (0.69–1.2)
Start date incorrect/missing 84 0.75 (0.41–1.09)
Provide drug product
Product/formulation not specified 450 4.01 (3.56–4.45)
Strength/dose missing 850 7.57 (7–8.14)
Route missing 111 0.99 (0.77–1.2)
No signature 210 1.87 (1.55–2.19)
Controlled drug requirements
incorrect/missing
53 0.47 (0.33–0.61)
Not recorded 1 0.01 (0–0.03)
Total 11,235 100
ADR adverse drug reaction, CI confidence interval, IV intravenous
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handwritten prescriptions (OR 0.88; 95 % CI 0.79–0.97)
after controlling for type of prescriber and the prescribing
stage at which the medication order was issued.
3.3 Predictors of Severity of Prescribing Error
There were no significant differences in severity of error in
the multinomial logistic regression model between types of
prescriber or whether the medication order was handwrit-
ten or generated electronically (Table 6). Potentially seri-
ous prescribing errors were significantly less likely to occur
on admission (OR 0.46; 95 % CI 0.33–0.66) or when a
drug chart was rewritten (OR 0.62; 95 % CI 0.39–0.98)
compared with when a medication order was issued during
the hospital stay.
Potentially serious prescribing errors were significantly
more likely to be associated with cardiovascular (OR
11.96; 95 % CI 7.92–18.06), central nervous system (OR
6.69; 95 % CI 4.21–10.64), anti-infective (OR 5.48; 95 %
CI 3.43–8.76), endocrine (OR 16.48; 95 % CI
10.27–26.46), and musculoskeletal and joint disease drugs
(OR 6.95; 95 % CI 4.21–11.49) than gastrointestinal drugs.
Parenteral routes of drug administration (intravenous/in-
tramuscular/subcutaneous) were also three times more
likely (OR 3.66; 95 % CI 2.98–4.49) to be associated with
serious (rather than minor) prescribing errors than was the
oral route of drug administration.
Table 7 presents the results from a multinomial logistic
regression with interaction terms to explore whether the
effect of therapeutic drug group on error severity differed
by the route of administration, adjusting for the factors
shown in Table 5 to be associated with prescribing error
severity. There was a 28-fold increase in the odds of a
serious prescribing error rather than minor for gastroin-
testinal drugs administered parenterally compared with
medication orders from the same therapeutic group that
were not injected (OR 28.63; 95 % CI 10.59–77.45). For
all other therapeutic drug groups, all routes of adminis-
tration had increased odds of serious errors compared with
gastrointestinal drugs, and the odds for potentially serious
errors were consistently higher for parenteral medication
orders.
Table 4 Number and rates of errors by severity and prescriber
Potential severity
Minor Significant Serious and potentially lethal Missing Total
Foundation Y1 1761 (40.3 [38.3–42.3]) 2285 (52.3 [50.3–54.3]) 323 (7.4 [6.5–8.3]) 0 4369 (100)
Foundation Y2 1480 (40.7 [38.5–43]) 1911 (52.6 [50.3–54.8]) 245 (6.7 [5.8–7.7]) 0 3636 (100)
FTSTAs 582 (41.9 [38.3–45.5]) 693 (49.9 [46.1–53.7]) 113 (8.1 [6.4–9.8]) 1 (0.07 [0–0.21]) 1389 (100)
NCCGs 143 (50.0 [41.9–58.1]) 125 (43.7 [35.8–51.6]) 18 (6.3 [3.3–9.2]) 0 286 (100)
Consultant 68 (43.3 [34.8–51.8]) 71 (45.2 [36.4–54]) 18 (11.5 [6.4–16.5]) 0 157 (100)
Pharmacist 0 6 (100.0) 0 0 6 (100)
Nurse 23 (43.4 [29.7–57.1]) 23 (43.4 [30.6–56.2]) 7 (13.2 [4.7–21.7]) 0 53 (100)
Not recorded 563 (42.0 [38.4–45.7]) 685 (51.2 [47.4–54.9]) 91 (6.8 [5.2–8.4]) 0 1339 (100)
Total 4620 (41.1 [39.9–42.4]) 5799 (51.6 [50.3–52.9]) 815 (7.25 [6.7–7.8]) 1 (0.01) 11,235 (100)
Data are presented as n (% [95 % CI])
CI confidence interval, FY foundation year 1 or 2 medical trainee, FTSTA fixed-term specialty training medical appointment, NCCG non-
consultant career grade medical staff, OR odds ratio
Table 5 Predictors of errors per order
Factor Univariable Multivariable
Prescriber
Consultant 1.0 1.0
Foundation Year 1 1.9 (1.61–2.24) 2.13 (1.8–2.52)
Foundation Year 2 2.24 (1.9–2.65) 2.23 (1.89–2.65)
FTSTAs 1.89 (1.59–2.24) 1.84 (1.54–2.19)
NCCGs 1.42 (1.16–1.75) 1.58 (1.29–1.94)
Pharmacist 0.55 (0.24–1.27) 0.84 (0.36–1.93)
Nurses 1.15 (0.83–1.58) 1 (0.71–1.39)
Electronic order
No 1.0 1.0
Yes 0.87 (0.79–0.95) 0.88 (0.79–0.97)
Prescribing stage
During stay 1.0 1.0
On admission 1.83 (1.74–1.93) 1.7 (1.61–1.8)
When drug chart re-written 0.51 (0.47–0.56) 0.48 (0.43–0.52)
Discharge prescription 0.82 (0.77–0.88) 0.77 (0.72–0.82)
Data are presented as OR (95 % CI)
CI confidence interval, FY foundation year 1 or 2 medical trainee,
FTSTA fixed-term specialty training medical appointment, NCCG
non-consultant career grade medical staff, OR odds ratio
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Table 6 Predictors of error
severity: multivariable
multinomial logistic models
Factor Odds of being a potentially
significant rather than a
minor error
Odds of being a potentially
serious rather than a
minor error
Patient age
Decades 1 (0.96–1.03) 0.93 (0.9–0.96)
Therapeutic drug group (BNF chapter)
1. Gastrointestinal 1.0 1.0
2. Cardiovascular 6.51 (5.12–8.27) 11.96 (7.92–18.06)
3. Respiratory 1.89 (1.34–2.67) 1.57 (0.61–4.04)
4. Central nervous system 1.79 (1.45–2.22) 6.69 (4.21–10.64)
5. Infections 2.8 (1.91–4.11) 5.48 (3.43–8.76)
6. Endocrine 3.42 (2.6–4.51) 16.48 (10.27–26.46)
7. Obstetrics, gynaecology and urinary tract – –
8. Malignant disease and immunosuppression – –
9. Nutrition and blood 1.48 (1.16–1.9) 1.13 (0.58–2.2)
10. Musculoskeletal and joint diseases 2.8 (1.82–4.31) 6.95 (4.21–11.49)
Route of administration
Oral 1.0 1.0
IV/IM/SC 1.07 (0.8–1.43) 3.66 (2.98–4.49)
Inhalers 1.38 (1–1.91) 0.37 (0.12–1.16)
Other 0.65 (0.45–0.92) 0.25 (0.09–0.71)
Error type
Need for drug 1.0 1.0
Selection of specific drug 0.35 (0.25–0.49) 2.41 (1.63–3.56)
Select dosage regimen 0.32 (0.27–0.38) 0.34 (0.26–0.46)
Administration of drug 0.04 (0.03–0.05) 0.03 (0.01–0.05)
Provide drug product 0.01 (0.01–0.01) 0.04 (0.02–0.06)
Prescriber
Consultant 1.0 1.0
Foundation Year 1 0.78 (0.48–1.25) 0.63 (0.27–1.45)
Foundation Year 2 0.74 (0.47, 1.16) 0.61 (0.26, 1.42)
FTSTAs 0.75 (0.45, 1.27) 0.68 (0.26, 1.75)
NCCGs 0.61 (0.35, 1.08) 0.39 (0.14, 1.08)
Pharmacist – 1.01 (0.46–2.22)
Nurses 0.81 (0.33–1.97) 0.6 (0.19–1.92)
Electronic
No 1.0 1.0
Yes 0.92 (0.76–1.11) 0.97 (0.76–1.23)
Prescribing stage
During stay 1.0 1.0
On admission 1.35 (1.07–1.71) 0.46 (0.33–0.66)
When drug chart re-written 0.75 (0.51–1.1) 0.62 (0.39–0.98)
Discharge prescription 1 (0.74–1.36) 0.75 (0.51–1.11)
BNF British National Formulary, CI confidence interval, IV/IM/SC intravenous/intramuscular/subcutaneous
administration route, FTSTA fixed-term specialty training medical appointments, NCCGs non-consultant
career grade medical staff, OR odds ratio
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4 Discussion
The problem of prescribing errors in hospitals is substantial
and not solely, or even primarily, a problem of the most
junior medical prescribers. In this large prospective study
in 20 NHS hospitals, prescribing errors occurred in 8.8 %
of newly prescribed medication orders, occurring more
commonly at hospital admission and on hand-written
orders than in those generated electronically. Doctors of all
grades made prescribing errors, as did non-medical pre-
scribers, but FY1 and FY2 doctors were more than twice as
likely to make prescribing errors as consultant doctors.
However, they were not more likely to make serious errors
than were more senior medical doctors.
This study was not without limitations. The errors were
identified by pharmacists as part of their routine work, a
common method of prescribing error data collection [8, 9,
16]. Failure either to identify or to record errors would
result in our data underestimating the actual error rate. Data
were recorded on 1 day per month to reduce the impact of
such data collection fatigue. Multiple pharmacists were
involved, leading to potential variations in data collection
practice, even with training. To minimise the impact, all
errors recorded were reviewed by a validation panel,
although we recognised this could not address variations
where errors were not identified or recorded. Identification
of the author of handwritten prescriptions is known to be
challenging [17], and the grade of the prescriber was not
recorded for 11 % of the medication orders in our study.
The impact of misidentification was minimised by having
the regular pharmacists, who were familiar with the sig-
natures of the regular doctors, collect the data. Nonetheless,
pharmacists only recorded the grade of the doctors writing
the prescription, rather than any other doctors involved in
making the prescribing decisions. Senior doctors often
instruct juniors on ward rounds as to what to write [18, 19],
and the error rate described here for senior doctors could be
an underestimate as to the erroneous prescribing with
which they were involved.
As with other recent British studies [8, 9], we have
found that prescribing errors are made by all grades of
doctors, not just those in their first year of post-graduate
training. Deficiencies in undergraduate medical education
can therefore only be part of the cause [20], and changes to
it, at best, only part of the solution. If education is to be a
means of reducing errors, it must include higher specialist
training and the continuing professional development of all
prescribers as well as education during the undergraduate
years and foundation training. Recent medical education
research has identified the importance of minimising the
negative effects of transitions [21]. In particular, it is well
recognised that an important transition occurs between
being an undergraduate student and being an early career
practitioner, and it has been consistently shown that ‘be-
coming a prescriber for real’ is one of its most dominant,
and negative, features [22, 23].
Trainees’ lack of experience in completing prescriptions
before they start work is a well-recognised problem [24], as
is the inappropriate satisfaction of some of them with
writing a prescription that ‘looks about right’ [25].
Although trainees in other studies have indicated that they
want more practical teaching [26], during undergraduate
education, at least, they needed the pressure of a summa-
tive assessment to motivate them to take it up [27]. In the
UK, the General Medical Council (GMC) revised their core
guidance for medical education, Tomorrow’s Doctors, to
recommend that formal prescribing skills training and
practical experience in the NHS be provided for medical
Table 7 Effect of route and administration and therapeutic drug group (BNF chapter) on severity of error (adjusted analyses)
Therapeutic drug group (BNF chapter) Odds of being a potentially significant rather
than a minor error (IV/IM/SC)
Odds of being a potentially serious rather
than a minor error (IV/IM/SC)
No Yes No Yes
1. Gastrointestinal 1.0 4.56 (1.71–12.2) 1.0 28.63 (10.59–77.45)
2. Cardiovascular 7.6 (6.08–9.51) 8.04 (5.34–12.09) 16.66 (10.41–26.64) 64.9 (37.66–111.84)
3. Respiratory 2.77 (2.19–3.52) 2.49 (0.72–8.63) 1.02 (0.51–2.03) 16.78 (1.99–141.79)
4. Central nervous system 2.15 (1.8–2.56) 0.9 (0.5–1.62) 10.87 (6.69–17.65) 12.57 (4.89–32.27)
5. Infections 3.04 (2.18–4.23) 4.52 (2.74–7.46) 11.39 (7.38–17.57) 22.62 (13.82–37.02)
6. Endocrine 4.33 (3.42–5.49) 1.98 (1.19–3.3) 22.17 (15.06–32.62) 92.84 (37.18–231.8)
7. Obstetrics, gynaecology and urinary tract – –
8. Malignant disease and immunosuppression – –
9. Nutrition and blood 1.48 (1.15–1.91) 5.29 (2.12–13.19) 1.24 (0.6–2.56) 21.31 (6.8–66.78)
10. Musculoskeletal and joint diseases 2.91 (1.9–4.46) 5.32 (0.9–31.25) 6.38 (2.54–16.06) 184.05 (33.12–1022.82)
Data are presented as OR (95 % CI)
BNF British National Formulary, CI confidence interval, IV/IM/SC intravenous/intramuscular/subcutaneous administration route, OR odds ratio
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students [28]. Alongside this, a new national assessment of
prescribing competence has also been introduced for all
medical students in the UK before they graduate from
medical school [29]. It will be important to evaluate the
impact of these recent developments on prescribing errors
to determine whether they lead to recognisable improve-
ments in patient safety. A study that explored junior doc-
tors’ experiences and responses to error found that learning
was maximised when errors were formally discussed and
constructive feedback was given [30], although Teunissen
et al. [31] have shown that trainees’ openness to negative
feedback depends on whether their primary motivation is to
be seen to be competent, or to learn from their mistakes.
Over half the errors found in this study were considered
significant with the potential to cause some form of
patient harm, similar to that found elsewhere [8], with a
further 7.3 % rated potentially serious or life threatening.
Serious prescribing errors were far more likely to occur
during a patient’s hospital stay and when prescribing
medication to be administered parenterally. These find-
ings present important early targets for future interven-
tions. Key questions are how and why these errors occur.
The quantitative analysis reported here was part of a large
mixed-methods study (EQUIP project) in which we also
interviewed 30 FY1 doctors about the causes of their
prescribing errors, and we draw on this work to interpret
our findings [32]. Complex systems were often involved
in causing errors, many of which related to the healthcare
environment within which doctors worked, including the
impact of busy and stressful working environments or
unfamiliarity of the system in which the doctor was
working. We found that the FY1 doctors often lacked
contextual, rather than basic, knowledge and had diffi-
culty framing clinical problems rather than necessarily
lacking specific drug knowledge. Prescribing errors were
often found to be due to multiple problems, with several
active failures and error-provoking conditions acting
together to result in errors. Given this, solutions aimed at
a single cause of error are likely to have only limited
impact, and multi-factorial interventions addressing many
parts of the process of prescribing are likely to be needed
[33].
The literature on causes of prescribing errors is rela-
tively sparse [33], and the qualitative research previously
conducted mainly concentrates on prescribing by junior
doctors, usually in the first year of their training. Much less
is known about the causes of prescribing errors by doctors
further into their training, such as FY2 doctors, and no
work has been conducted focusing on causes of errors
made by senior doctors or non-medical prescribers,
although this study shows that they occur. More needs to be
understood about errors made by senior doctors to inform
the necessary continuing professional development
delivery and systems redesign that is needed to improve
patient safety.
Although we found that prescribing errors were 12 %
less likely to occur with electronic prescribing systems, we
found no difference in the likelihood of serious prescribing
errors occurring between hand-written and electronically
generated medication orders. This supports the findings
from a systematic review of 12 studies that reported
computerised provider order-entry systems can reduce
minor prescribing errors, with some studies suggesting
increasing rates of some more serious errors, such as
duplicating orders or failure to discontinue medicines no
longer needed [34].
The stage of the patient’s hospital stay during which
errors, particularly significant errors, were more likely to
occur was at the point of admission and, at that stage,
failure to prescribe pre-admission medication was the most
common error. There is evidence that conducting medici-
nes reconciliations as soon as possible after admission will
reduce omission of long-term medicines [35–37]. Medici-
nes reconciliation is the process by which an up-to-date and
accurate list of medicines is created at transitions of care,
using information collected from multiple sources as to the
pre-admission medication, checked with the current pre-
scribed medicines, and any discrepancies communicated in
writing with the current care team [38]. Our findings sup-
port the need for medication reconciliations to improve
medication safety at transition points between healthcare
settings.
5 Conclusion
This study found that junior doctors were twice as likely as
senior doctors to make prescribing errors, but that they had
similar rates of potentially serious prescribing errors.
Potentially serious errors were more likely to be associated
with prescriptions for parenteral administration, especially
for cardiovascular or endocrine disorders. Further research
is needed to target interventions to reduce these high-risk
errors and to improve patient safety.
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